Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists

Mostrar otras versiones (1)

This paper describes the structure-based design of a preliminary drug candidate against COVID-19 using free software and publicly available X-ray crystallographic structures. The goal of this tutorial is to disseminate skills in structure-based drug design and to allow others to unleash their own cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Krumberger, Maj, Morris, Michael A., Parrocha, Chelsea Marie T., Kreutzer, Adam G., Nowick, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980496/
https://www.ncbi.nlm.nih.gov/pubmed/33812315
http://dx.doi.org/10.1016/j.ejmech.2021.113390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980496/
https://www.ncbi.nlm.nih.gov/pubmed/33812315
http://dx.doi.org/10.1016/j.ejmech.2021.113390

Ejemplares similares